Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. kosovo
  4. particle sizing
Show results for
Products
Services
Training
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • This Year
  • Older

Particle Sizing Articles & Analysis

22 news found

CD Bioparticles Launches Purified Exosomes for Drug Delivery and Therapeutic Research

CD Bioparticles Launches Purified Exosomes for Drug Delivery and Therapeutic Research

CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the availability of its quality Purified Exosomes to support research in drug delivery, regenerative medicine, and various therapeutic applications. Exosomes are extracellular vesicles secreted by human cells that exhibit biofilm characteristics. They have a particle size of 30-150 ...

ByCD Bioparticles


The Effect of Combined Exercise and Diet on Obese Mice

The Effect of Combined Exercise and Diet on Obese Mice

Obesity is a metabolic condition resulting from an imbalance between the energy consumed and the energy expended. This is often caused by an increase in the intake of calorie-dense foods and a decrease in physical activity, leading to an abnormal build-up of fat. Such fat accumulation can have serious health consequences, raising the risk of chronic diseases like cardiovascular conditions, ...

BySCIREQ - an emka TECHNOLOGIES Company


CD Bioparticles Simplifies Multi-Analyte Detection with Advanced Multiplex Particles

CD Bioparticles Simplifies Multi-Analyte Detection with Advanced Multiplex Particles

With years of experience in the pharmaceutical and life science sectors, CD Bioparticles announces its advanced line of multiplex fluorescence particles designed to streamline complex biological assays in flow cytometry experiments. These particles exhibit low signal widths in the forward scatter, side scatter and fluorescence channels. Various surface modifications, channels and sizes are also ...

ByCD Bioparticles


CD Formulation Excels in Developing and Optimizing Micro-Reservoir Controlled-Release Drug Delivery Systems   

CD Formulation Excels in Developing and Optimizing Micro-Reservoir Controlled-Release Drug Delivery Systems  

CD Formulation has been dedicated to pharmaceutical advancements, showcasing immense expertise in the development and optimization of micro-reservoir controlled-release drug delivery systems. These innovative systems have revolutionized the way medications are administered, enhancing patient comfort and ensuring optimal therapeutic efficacy. Transdermal drug delivery systems are very popular ...

ByCD Formulation


CD Formulation Introduces Powder Flowability Testing to Maximize Tablet Performance   

CD Formulation Introduces Powder Flowability Testing to Maximize Tablet Performance  

In the pursuit of optimizing tablet performance, CD Formulation, a leading provider of pharmaceutical analysis services, has unveiled a groundbreaking powder flowability testing method. This cutting-edge technology promises to revolutionize tablet manufacturing by ensuring high-quality and consistent tablet production for pharmaceutical companies worldwide. Powder flowability plays a crucial ...

ByCD Formulation


CD Formulation Provides Efficient Strategies to Develop and Optimize Microspheres & Microneedles

CD Formulation Provides Efficient Strategies to Develop and Optimize Microspheres & Microneedles

In recent years, the field of drug delivery has experienced significant advancements in the development of innovative delivery systems such as microspheres and microneedles. These advanced systems offer unique benefits, including enhanced drug stability, sustained release, and targeted delivery. However, the successful formulation and optimization of these delivery systems pose significant ...

ByCD Formulation


Research on Safe Nebulizer Inhalation Therapy Using Clean Booth and Particle Counters

Research on Safe Nebulizer Inhalation Therapy Using Clean Booth and Particle Counters

Particles Plus® instruments have once again been used by scientists for research into Nebulizer Inhalation Therapy. To test the administration of safe Nebulizer Inhalation Therapy, researchers monitored particle concentrations for different particle sizes with Particles Plus® Optical Particle Counters (OPC). Optical Particle Counters can measure particle size distribution and particle ...

ByParticles Plus, Inc.


CD Formulation Provides In Vitro Cytotoxicity Testing for Microspheres and Microneedles   

CD Formulation Provides In Vitro Cytotoxicity Testing for Microspheres and Microneedles  

In recent years, the field of drug delivery has witnessed great advancements in the development of microspheres and microneedles, revolutionizing the way drugs are administered. These innovative technologies offer targeted and sustained release of therapeutic agents, promoting improved patient compliance and efficacy. However, as with any medical product, it is crucial to assess the safety and ...

ByCD Formulation


CD Formulation: Prescription Screening Process Analysis Provides New Possibilities for Pharmaceutical Industry

CD Formulation: Prescription Screening Process Analysis Provides New Possibilities for Pharmaceutical Industry

CD Formulation, a leading CRO specialized in pharmaceutical formulation, has launched a new prescription screening process analysis service for both existing and new customers across the globe. The goal is to provide drug manufacturers with accurate and reliable results. Moreover, the technology used in this process is capable of detecting impurities and other contaminants in prescription drug ...

ByCD Formulation


CD Formulation: Pharmaceutical Analysis Brings More Confidence to Drug Development and GMP Manufacturing

CD Formulation: Pharmaceutical Analysis Brings More Confidence to Drug Development and GMP Manufacturing

Equipped with a cGMP-compliant laboratory and state-of-the-art analytical instruments, CD Formulation’s seasoned research team is well-prepared to handle the most complicated drug analytical issues as a contract service organization. The samples to be tested and analyzed could be in the form of solids, semi-solids, liquids, or gases. In brief, pharmaceutical analysis involves a series of ...

ByCD Formulation


CD Bioparticles Launches NIR-Quantum Dots for Biomedical Imaging

CD Bioparticles Launches NIR-Quantum Dots for Biomedical Imaging

With years of experience in the pharmaceutical and life science sector, CD Bioparticles launched a range of near-infra-red (NIR) quantum dots that exhibit excellent optical properties and biocompatibility for biomedical imaging. Currently, CD Bioparticles has successfully synthesized a variety of NIR quantum dots, including PbS/CdS, PbS, PbSe, Ag2S, CuInS/ZnS, and CdTe/CdSe/ZnS. Quantum points ...

ByCD Bioparticles


CD Formulation Strengthens Its Role as a CRO Company for Pharmaceuticals   

CD Formulation Strengthens Its Role as a CRO Company for Pharmaceuticals  

Combining robust expertise and years of experience, the US-based company CD Formulation further strengthens its role as a contract service provider for pharmaceutical companies in a recent statement. Though the service portfolio of CD Formulation is far-ranged and nearly covers the whole process of drug formulation, encompassing pre-formulation, formulation, drug analysis, solubility improvement ...

ByCD Formulation


CD Formulation Offers Insights, Strategies, and Practical Suggestions on Pre-formulation Studies for Pharmaceuticals

CD Formulation Offers Insights, Strategies, and Practical Suggestions on Pre-formulation Studies for Pharmaceuticals

In a recent statement, the US-based CRO company CD Formulation re-demonstrated its competence in drug development and announced that it now offers industry-leading insights, strategies, and practical suggestions on pre-formulation studies for drug developers worldwide. The past decade has witnessed a boom of new chemical entities development in the hope of bringing more therapies to diseases hard ...

ByCD Formulation


CD Formulation Expands Its Service Portfolio for Drug Delivery Research

CD Formulation Expands Its Service Portfolio for Drug Delivery Research

As a reliable service provider in pharmaceutical formulation development, CD Formulation constantly expands its service range and today announces to offer a comprehensive portfolio of services for drug delivery system (DDS) research, including microneedle technology services, oral thin films technology services, microencapsulation technology services, liposome drug delivery technology services, ...

ByCD Formulation


CD Formulation Provides Comprehensive Formulation Development and Analytical Services for the pharmaceutical Industry

CD Formulation Provides Comprehensive Formulation Development and Analytical Services for the pharmaceutical Industry

Formulation development is of paramount importance for new drug development as it can determine patentability, lifecycle and, ultimately, the success of a pharmaceutical product. Fully aware of the challenges that may arise from this process, CD Formulation recently announces that it now provides a comprehensive range of formulation development and analytical services for the pharmaceutical ...

ByCD Formulation


CD Formulation Is Able to Conduct API-Excipient Compatibility Analysis for Drug Development

CD Formulation Is Able to Conduct API-Excipient Compatibility Analysis for Drug Development

As a service provider for custom pharmaceutical formulation projects, CD Formulation announces today that it is able to conduct API-excipient compatibility analysis service for clients across the globe with drug development demands. “The testing and analysis of the API-excipient compatibility is an extremely critical step in the drug preformualtion stage. We know that a drug substance is ...

ByCD Formulation


CD Formulation Announces to Optimize Stability Analysis for Drug Pre-formulation Research

CD Formulation Announces to Optimize Stability Analysis for Drug Pre-formulation Research

Recognized as a CRO for pharmaceutical formulation, CD Formulation recently announces to have optimized its stability analysis service, providing solid-state stability analysis, solution-state stability analysis, APIs-excipients compatibility analysis for researchers devoted to drug formulation research. Current Good Manufacturing Practice for Finished Pharmaceuticals (CGMPs) has already ...

ByCD Formulation


CD Formulation Releases Solubility Analysis to Assist Drug R&D Projects

CD Formulation Releases Solubility Analysis to Assist Drug R&D Projects

Solubility measurement is a key element for a preliminary understanding of the pharmacodynamic properties of the drug. On August 30, 2021, CD Formulation, a leading CRO service provider in the industry, announces the release of drug solubility analysis, which is an indispensable step in drug development and formulation to ensure efficacy and quality of drugs. Drug substances have to be dissolved ...

ByCD Formulation


Abera Initiates the Development of a New Vaccine Candidate Through a Collaboration Agreement With American University

Abera Initiates the Development of a New Vaccine Candidate Through a Collaboration Agreement With American University

Abera Bioscience AB is a biotechnology company that develops vaccine candidates based on patented vaccine platforms. The latest vaccine platform makes it possible to produce single, or multiple, antigens in so-called protein bodies. Antigens are the pathogen-specific components of vaccines that elicit immune responses. Protein bodies are nano-sized protein particles. The company is now entering ...

ByAbera Bioscience AB


National Patient Safety Agency Alert Concerning Nebulisers

National Patient Safety Agency Alert Concerning Nebulisers

The National Patient Safety Agency recently issued an alert (NatPSA/2021/003/NHSPS) necessitating organisations to “purchase sufficient powered nebuliser devices for use across the organisation; to remove the need for medical air to drive nebulisers via a flowmeter”. It states that all NHS hospitals are required to be fully compliant by the 16th November 20211. Aerogen, vibrating ...

ByAerogen

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT